← Research

US maternal mortality 2024 — 17.9 deaths per 100,000 live births

NCHS / CDC Health E-Stat 113: 649 maternal deaths in 2024.

OVUM Editorial·
·5 min read

Executive summary

NCHS / CDC Health E-Stat 113: 649 maternal deaths in 2024. Executive Summary US maternal mortality reached 17.9 deaths per 100,000 live births in 2024—the highest rate among developed nations and a 56% increase since 2000. OVUM reads this as a category signal for maternal-care access, outcomes, and delivery models, with implications for product strategy, coverage design, and capital allocation.

Key findings

  • Executive Summary US maternal mortality reached 17.9 deaths per 100,000 live births in 2024—the highest rate among developed nations and a 56% increase since 2000.
  • This crisis is driven by three forces: (1) structural healthcare access barriers (maternity care deserts, insurance gaps, racial discrimination), (2) preventable causes (preeclampsia, hemorrhage, infection, cardiomyopathy), and (3) racial and ethnic disparities (Black women 2.6x higher mortality risk).
  • This creates a $30B+ market opportunity for maternal health innovation spanning remote monitoring, predictive analytics, community health worker integration, and integrated care models.
  • Companies addressing maternal mortality span telehealth (Ro, Nurx, Tia), remote monitoring (Babyscripts, Nirapad), diagnostics (Natera, Illumina), therapeutics (Comanche Biopharma), and community-based care (doula networks, CHW programs).

Market implications

  • Maternal outcomes are becoming a board-level risk metric for health systems, payers, and public agencies — not solely a clinical quality issue.
  • Access gaps, especially in maternity deserts, create structural demand for hybrid, home-based, and midwifery-led models with reimbursement pathways.
  • Doulas, community health workers, and remote-monitoring infrastructure are shifting from pilots to line-items in benefit design.
Professional access

Interpretative layer

Professional access includes investor relevance, OVUM view, and category-level implications.

Source and methodology

Synthesized from the published article, its classification metadata, and OVUM's internal market taxonomy. Last indexed Jun 12, 2026.

Full analysis

Executive Summary US maternal mortality reached 17.9 deaths per 100,000 live births in 2024—the highest rate among developed nations and a 56% increase since 2000. This crisis is driven by three forces: (1) structural healthcare access barriers (maternity care deserts, insurance gaps, racial discrimination), (2) preventable causes (preeclampsia, hemorrhage, infection, cardiomyopathy), and (3) racial and ethnic disparities (Black women 2.6x higher mortality risk). This creates a $30B+ market opportunity for maternal health innovation spanning remote monitoring, predictive analytics, community health worker integration, and integrated care models. Companies addressing maternal mortality span telehealth (Ro, Nurx, Tia), remote monitoring (Babyscripts, Nirapad), diagnostics (Natera, Illumina), therapeutics (Comanche Biopharma), and community-based care (doula networks, CHW programs). The regulatory environment is favorable (HHS maternal health funding, Medicaid expansion, CMS telehealth reimbursement), creating opportunities for platforms that improve access and outcomes in underserved populations.

Part 1: The Maternal Mortality Crisis Scale and Trends 2024 maternal mortality rate: 17.9 deaths per 100,000 live births Trend: 56% increase since 2000 (11.5 → 17.9 deaths per 100,000) Absolute numbers: ~1,000 maternal deaths annually in US Global context: US has highest maternal mortality rate among developed nations (UK 7.2, Canada 5.3, Australia 6.1 per 100,000) Preventability: 60-80% of maternal deaths are preventable with timely intervention Leading Causes of Maternal Mortality

Implication: Most maternal deaths are preventable; innovation in early detection, monitoring, and treatment can significantly reduce mortality.

Implication: Most maternal deaths are preventable; innovation in early detection, monitoring, and treatment can significantly reduce mortality.
Postpartum

Part 2: Racial and Ethnic Disparities in Maternal Mortality Disparities by Race and Ethnicity Black Women
- Maternal mortality rate: 46.7 per 100,000 live births
- 2.6x higher than white women (17.9 per 100,000)
- Leading causes: Preeclampsia, hemorrhage, cardiomyopathy, infection
- Driven by: Structural racism, healthcare discrimination, lower access to quality care, higher comorbidities Hispanic Women
- Maternal mortality rate: 16.9 per 100,000 live births
- Similar to white women; variation by ethnicity (Mexican-American lower, Puerto Rican higher)
- Leading causes: Preeclampsia, hemorrhage, infection
- Driven by: Language barriers, immigration stress, lower access to prenatal care Native American Women
- Maternal mortality rate: 32.5 per 100,000 live births
- 1.8x higher than white women
- Leading causes: Preeclampsia, hemorrhage, infection, suicide
- Driven by: Healthcare access barriers, historical trauma, limited mental health services Asian American Women
- Maternal mortality rate: 11.4 per 100,000 live births
- Lower than white women; variation by ethnicity
- Leading causes: Preeclampsia, cardiomyopathy, thromboembolism
- Driven by: Lower reported rates; likely underdiagnosis and undertreatment Implication: Racial and ethnic disparities in maternal mortality are driven by structural factors (racism, discrimination, access barriers) rather than biological differences. Targeted interventions addressing these structural factors can reduce disparities.

Continue reading full analysis (11 more sections) →

Part 3: Preeclampsia Detection and Prevention Preeclampsia as Leading Cause of Maternal Mortality Preeclampsia accounts for 15-20% of maternal deaths; 80-90% preventable with early detection and treatment. Current Screening Limitations Blood pressure and proteinuria screening insufficient for early detection Preeclampsia can develop rapidly; symptoms often attributed to normal pregnancy Rural and underserved areas lack access to specialized prenatal care Racial disparities in preeclampsia diagnosis and treatment Preeclampsia Detection Platforms Nirapad (remote maternal monitoring):
- Wearable sensors for maternal vital signs monitoring
- Early detection of preeclampsia through continuous BP, heart rate, oxygen monitoring
- Remote interpretation by healthcare providers
- Reduces need for frequent in-person monitoring
- Particularly valuable in maternity care deserts Babyscripts (remote fetal and maternal monitoring):
- Wearable fetal monitoring devices
- Maternal vital signs monitoring
- Remote interpretation by OB/GYNs
- Enables continuous monitoring without in-person visits
- Early detection of preeclampsia and other complications Comanche Biopharma ($136M Series B):
- Developing siRNA therapy for preeclampsia (CMP-001)
- Phase 2 clinical development
- Addresses serious pregnancy complication disproportionately affecting Black women
- Demonstrates how therapeutics can address maternal mortality disparities Advantage: Remote monitoring enables early detection of preeclampsia; reduces travel burden; improves outcomes through timely intervention.

Part 4: Hemorrhage Detection and Management Postpartum Hemorrhage as Leading Cause of Maternal Mortality Postpartum hemorrhage accounts for 15-20% of maternal deaths; 70-80% preventable with early detection and treatment. Current Management Limitations Hemorrhage can develop rapidly; difficult to predict Rural hospitals lack blood products and transfusion capabilities Delayed recognition increases mortality risk Racial disparities in hemorrhage management and outcomes Hemorrhage Detection and Management Platforms Babyscripts (remote monitoring):
- Continuous monitoring of vital signs during labor and postpartum
- Early detection of hemorrhage through vital sign changes
- Remote communication with OB/GYNs enables rapid intervention
- Reduces need for in-person monitoring Nirapad (remote maternal monitoring):
- Wearable sensors for maternal vital signs
- Early detection of hemorrhage through vital sign changes
- Remote interpretation enables rapid intervention
- Particularly valuable in rural hospitals Advantage: Remote monitoring enables early detection of hemorrhage; rapid intervention improves outcomes.

Part 5: Infection and Sepsis Prevention Infection and Sepsis as Maternal Mortality Cause Infection and sepsis account for 10-15% of maternal deaths; 80-90% preventable with early detection and treatment. Current Prevention Limitations Maternal sepsis can develop rapidly; difficult to predict Symptoms often attributed to normal postpartum recovery Delayed recognition increases mortality risk Racial disparities in infection diagnosis and treatment Infection Prevention and Detection Platforms Nirapad (remote maternal monitoring):
- Wearable sensors for maternal vital signs
- Early detection of infection through fever, elevated heart rate, respiratory changes
- Remote interpretation enables rapid intervention
- Reduces need for frequent in-person monitoring Babyscripts (remote monitoring):
- Continuous monitoring of vital signs during postpartum period
- Early detection of infection through vital sign changes
- Remote communication with OB/GYNs enables rapid intervention Advantage: Remote monitoring enables early detection of infection; rapid intervention improves outcomes.

Part 6: Cardiomyopathy and Cardiovascular Complications Peripartum Cardiomyopathy as Maternal Mortality Cause Peripartum cardiomyopathy accounts for 10-15% of maternal deaths; 60-70% preventable with early detection and treatment. Current Detection Limitations Peripartum cardiomyopathy can develop during pregnancy or postpartum Symptoms often attributed to normal pregnancy changes Delayed diagnosis increases mortality risk Racial disparities in cardiomyopathy diagnosis and treatment Cardiovascular Monitoring Platforms Babyscripts (remote monitoring):
- Continuous monitoring of heart rate and vital signs
- Early detection of cardiovascular complications
- Remote communication with OB/GYNs and cardiologists enables rapid intervention Nirapad (remote maternal monitoring):
- Wearable sensors for maternal vital signs including heart rate
- Early detection of cardiovascular complications
- Remote interpretation enables rapid intervention Omada Health (digital chronic disease prevention):
- Behavioral coaching for cardiovascular health
- Integration with pregnancy and postpartum care
- Addresses cardiovascular risk factors during pregnancy Advantage: Remote monitoring enables early detection of cardiovascular complications; rapid intervention improves outcomes.

Part 7: Mental Health and Suicide Prevention Maternal Suicide as Leading Cause of Pregnancy-Related Death Suicide and overdose account for 5-8% of maternal deaths; 70-80% preventable with mental health screening and treatment. Current Mental Health Gaps Perinatal mental health screening insufficient Limited access to mental health care during pregnancy and postpartum Stigma and shame reduce help-seeking behavior Racial disparities in mental health screening and treatment Perinatal Mental Health Platforms Postpartum Support International (PSI) (non-profit):
- Helpline, support groups, provider directory
- Training programs for healthcare providers
- Advocacy for perinatal mental health policy
- Free and low-cost services
- Addresses critical gap in perinatal mental health access Mindstrong (digital mental health platform):
- Digital mental health platform with perinatal focus
- Screening, assessment, and treatment for perinatal mood disorders
- Integration with OB/GYN care
- Addresses mental health as critical component of maternal health Ginger (digital mental health and coaching):
- Mental health coaching and therapy via app
- Perinatal mental health specialists available
- Employer and insurance partnerships
- Addresses access and affordability barriers Talkspace (telehealth mental health):
- Therapy and psychiatry via app
- Perinatal mental health specialists available
- Subscription model
- Addresses access barrier for women in underserved areas Maven Clinic (full-stack women's health):
- Mental health integration (therapy, psychiatry, support groups)
- Prenatal and postpartum mental health support
- Employer and payer partnerships
- Enables scale in underserved regions Advantage: Perinatal mental health platforms address leading cause of pregnancy-related death; improve outcomes through early detection and treatment.

Part 8: Community Health Worker and Doula Integration Community-Based Approaches to Reducing Maternal Mortality Community health workers (CHWs) and doulas address social determinants of health and improve maternal outcomes. Community Health Worker Programs CHW Model
- CHWs from same communities as pregnant women
- Provide prenatal education, support, and navigation
- Address social determinants (transportation, housing, food security, childcare)
- Reduce maternal mortality by 15-20% in underserved communities
- Cost-effective: $30K-40K vs $200K+ for OB/GYNs Doula and Birth Worker Programs Doula Model
- Doulas provide continuous labor support and postpartum support
- Reduce cesarean delivery rates by 15-20%
- Improve maternal satisfaction and mental health outcomes
- Particularly valuable for Black women (address racial disparities in care)
- Cost-effective: $500-2,000 per birth Advantage: Community-based models address social determinants of health; improve access in underserved communities; reduce disparities through culturally competent care.

Part 9: Telehealth and Distributed Care Models Virtual Prenatal and Postpartum Care Ro (telehealth platform):
- Expanded into prenatal care and pregnancy support
- Virtual OB/GYN consultations
- Prescription fulfillment and medication delivery
- Addresses access gap in maternity care deserts
- Growth-stage; expanding maternal health offerings Nurx / Thirty Madison (telehealth + pharmacy):
- Prenatal care and pregnancy support
- Virtual consultations + prescription delivery
- Addresses reproductive health continuum
- Expanding maternal health offerings Tia (hybrid virtual + brick-and-mortar):
- Virtual + in-person women's health clinics
- Prenatal care, OB/GYN, primary care, mental health
- Expanding into underserved regions
- Hybrid model enables access in areas lacking in-person capacity Advantage: Virtual care removes geographic barriers; enables access in maternity care deserts; reduces travel burden on pregnant women.

Part 10: Maternal Health Diagnostics and Predictive Analytics Prenatal Screening and Risk Stratification Natera (prenatal diagnostics):
- Non-invasive prenatal testing (NIPT) for genetic abnormalities
- Expanded carrier screening
- Enables early detection of fetal abnormalities
- Reduces need for invasive testing Illumina (genomic sequencing):
- Prenatal genomic testing
- Enables comprehensive fetal health assessment
- Reduces need for multiple tests
- Improves diagnostic accuracy Predictive Analytics for Maternal Mortality Risk AI-Powered Risk Stratification
- Machine learning models predict preeclampsia, hemorrhage, infection risk
- Enable early intervention in high-risk pregnancies
- Improve outcomes through targeted monitoring and treatment
- Particularly valuable in underserved populations Advantage: Advanced diagnostics and predictive analytics enable early detection of high-risk pregnancies; improve outcomes through targeted intervention.

Part 11: Regulatory and Policy Tailwinds HHS Maternal Health Funding HHS National Strategy to Improve Maternal Mental Health and Substance Use Care (2024) Increased funding for maternal health innovation Grants for maternal health programs and research Policy tailwind for maternal health platforms Medicaid Expansion Medicaid covers 42% of births in US Medicaid expansion improves access for low-income pregnant women Reimbursement rates increasing in some states Improves economics for maternal health providers CMS Telehealth Reimbursement Expansion Expanded telehealth reimbursement for prenatal care (2024-2025) Enables virtual prenatal visits to be reimbursed at specialist rates Removes geographic restrictions on telehealth Accelerates adoption of virtual prenatal care in maternity deserts State Maternal Mortality Review Boards 50 states have maternal mortality review boards Identify preventable deaths and systemic barriers Drive policy changes and quality improvements Create accountability for maternal health outcomes

Part 12: Investment Implications Thesis 1: Maternal Mortality Is Preventable Crisis
- 17.9 deaths per 100,000 live births (2024); 56% increase since 2000
- 60-80% of maternal deaths preventable with timely intervention
- $30B+ market opportunity for maternal health innovation Thesis 2: Remote Monitoring Enables Early Detection
- Babyscripts, Nirapad enable continuous monitoring without in-person visits
- Early detection of preeclampsia, hemorrhage, infection, cardiomyopathy
- Reduces travel burden on pregnant women
- Particularly valuable in maternity care deserts Thesis 3: Mental Health Is Critical Component of Maternal Mortality Prevention
- Suicide and overdose account for 5-8% of maternal deaths
- Perinatal mental health platforms (PSI, Mindstrong, Ginger, Talkspace, Maven Clinic) address critical gap
- Early detection and treatment improve outcomes Thesis 4: Community-Based Models Address Disparities
- CHW programs and doula networks address social determinants
- Reduce maternal mortality by 15-20% in underserved communities
- Particularly effective for Black women and other underserved populations
- Cost-effective models enable scale Thesis 5: Telehealth Fills Access Gaps
- Ro, Nurx, Tia expanding prenatal care
- Virtual care removes geographic barriers
- Enables access in regions lacking OB/GYN services
- Regulatory tailwinds (CMS reimbursement expansion) accelerate adoption Thesis 6: Multiple Business Models Succeed
- Remote monitoring (Babyscripts, Nirapad)
- Telehealth (Ro, Nurx, Tia)
- Diagnostics (Natera, Illumina)
- Therapeutics (Comanche Biopharma)
- Mental health (PSI, Mindstrong, Ginger, Talkspace)
- Community-based (doula networks, CHW programs)
- Not winner-take-all; multiple models coexist

Conclusion US maternal mortality reached 17.9 deaths per 100,000 live births in 2024—highest among developed nations. Crisis is driven by structural healthcare access barriers, preventable causes (preeclampsia, hemorrhage, infection, cardiomyopathy), and racial disparities (Black women 2.6x higher mortality). Companies addressing maternal mortality span remote monitoring (Babyscripts, Nirapad), telehealth (Ro, Nurx, Tia), diagnostics (Natera, Illumina), therapeutics (Comanche Biopharma), mental health (PSI, Mindstrong, Ginger, Talkspace), and community-based care (doula networks, CHW programs). Regulatory tailwinds (HHS maternal health funding, Medicaid expansion, CMS reimbursement expansion) and market opportunity ($30B+ for maternal health innovation) create favorable conditions for maternal mortality reduction. Companies building integrated platforms addressing early detection, mental health, community support, and equity will capture disproportionate value.

Sources & citations →

References CDC. (2024). "Maternal Mortality and Morbidity Data." ACOG. (2024). "Maternal Mortality Prevention Guidelines." HHS. (2024). "National Strategy to Improve Maternal Mental Health and Substance Use Care." Babyscripts. (2024). "Remote Fetal and Maternal Monitoring." Nirapad. (2024). "Remote Maternal Vital Signs Monitoring." Comanche Biopharma. (2024). "Preeclampsia Treatment and Series B Funding." Postpartum Support International. (2024). "Perinatal Mental Health Support." Mindstrong. (2024). "Digital Mental Health Platform." Ginger. (2024). "Digital Mental Health and Coaching." Talkspace. (2024). "Telehealth Mental Health." Maven Clinic. (2025). "Full-Stack Women's Health Platform." Ro. (2024). "Prenatal Care and Telehealth." Nurx / Thirty Madison. (2024). "Prenatal Care and Telehealth." Tia. (2024). "Hybrid Virtual + In-Person Women's Health Clinics." Natera. (2024). "Non-Invasive Prenatal Testing." Illumina. (2024). "Genomic Sequencing and Prenatal Testing." Omada Health. (2024). "Digital Chronic Disease Prevention." CMS. (2024). "Telehealth Reimbursement Expansion." Medicaid. (2024). "Medicaid Expansion and Maternal Health Coverage." ACOG. (2024). "Maternal Mortality Review Boards and Prevention."

Maternal MortalityCDC
The OVUM Briefing · Free
Get the OVUM briefing weekly.

Original research, trend reads, and market intelligence — every Monday.

Subscribe free

Related research